Psyched: 1-Canada's Access To Psychedelic Medicines, Psilocybin No Cognitive Side Effects 2-Psilocybin Bill Washington
Category: News & PoliticsVia: krishna • 4 months ago • 8 comments
By: by Natan Ponieman
Full Disclosure: I own shares of MNMD, one of several companies researching the legitimate use of psychedlics for medicinal purposes.
Disclaimer: Nothing in this seed is to be considered as advice to buy or sell any stock. Investing in the stock market may result in the loss of some or all of your invested capital.
Canada Opens New Legal Pathways For Access To Treatment With Psilocybin And MDMA
In a groundbreaking decision,the Canadian government is changing the way patients can access psychedelic therapies with restricted drugs , including MDMA and psilocybin.
Through an amendment to federal regulations, Health Canada is now allowing physicians to request access to restricted drugs on behalf of patients through the Special Access Program(SAP) , a program meant to streamline access to special treatments for patients with serious or life-threatening conditions in instances where other therapies have failed or are unsuitable.
While the official communication made sure to note that “this regulatory change will not result in large-scale authorization for access to restricted drugs,” the event can be seen as an official acknowledgment of MDMA and psilocybin’s therapeutic potential and eventually lead to further decriminalization measures.
New Bill Introduced In Washington State Would Legalize Psilocybin
Lawmakers in Washington State introduced a bill that would create a state-licensed program to provide medical treatment with psilocybin, the active compound in magic mushrooms.